Related Experiment Video

Updated: Jul 6, 2025

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

17.6K

Current and future trends in neoadjuvant immunotherapy for the treatment of triple-negative breast cancer

Ramon Andrade de Mello1,2,3, Kátia Roque Perez3,4, Thais Pérez Vazquez5

  • 1Department of Oncology, Oxford Cancer Center, Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, OX3 7LE, Oxford, UK.

Immunotherapy
|January 10, 2024
PubMed

Insights

Triple-negative breast cancer (TNBC) treatment is advancing with chemotherapy and immunotherapy combinations. Future research focuses on new drugs and pathways for better neoadjuvant therapies.

Area of Science:

  • Oncology
  • Immunology
  • Metabolic pathways

Background:

  • Triple-negative breast cancer (TNBC) accounts for 15-20% of all breast cancer cases.
  • TNBC lacks targeted therapy options, necessitating research into novel treatment strategies.
  • Current neoadjuvant treatment involves chemotherapy combined with immunotherapy due to observed response improvements.

Purpose of the Study:

  • To review the latest therapeutic updates for TNBC.
  • To explore potential advancements in neoadjuvant treatment for TNBC.
  • To identify new immunological and metabolic pathways for enhanced treatment efficacy.

Main Methods:

  • Literature review of recent clinical investigations and therapeutic advancements in TNBC.
  • Analysis of current neoadjuvant treatment protocols, including chemotherapy and immunotherapy combinations.
  • Exploration of emerging research on immunological and metabolic targets.

Main Results:

  • The combination of chemotherapy and immunotherapy has shown improved response rates in neoadjuvant TNBC treatment.
  • Ongoing research aims to identify novel drugs with higher response potential.
  • Investigation into immunological and metabolic pathways may reveal new therapeutic targets.

Conclusions:

  • Neoadjuvant treatment for TNBC is evolving, with immunotherapy combinations showing promise.
  • Further research into novel agents and biological pathways is crucial for improving outcomes.
  • The future of TNBC treatment lies in personalized approaches targeting unique disease characteristics.
Keywords:
breast cancerimmunotherapyneoadjuvant treatmentnew targetstriple negative

More Related Videos

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

12.2K
Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

11.5K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
527
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
368
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K